|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn609997294 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
070610s2007 enk ob 001 0 eng d |
040 |
|
|
|a QE2
|b eng
|e pn
|c QE2
|d E7B
|d OCLCQ
|d N$T
|d IDEBK
|d OCLCQ
|d DG1
|d FVL
|d OCLCQ
|d NLGGC
|d YDXCP
|d EBLCP
|d MERUC
|d BTCTA
|d UKDOC
|d OCLCQ
|d COO
|d OCLCQ
|d DEBBG
|d AZK
|d IAS
|d OCLCQ
|d COCUF
|d TOA
|d AGLDB
|d DG1
|d CHVBK
|d OCLCQ
|d MOR
|d LIP
|d PIFAG
|d ZCU
|d OCLCQ
|d U3W
|d OCLCQ
|d OCLCF
|d OCLCO
|d JBG
|d OCLCO
|d STF
|d WRM
|d VNS
|d OCLCO
|d VTS
|d NRAMU
|d ICG
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d WYU
|d OCLCO
|d OCLCA
|d TKN
|d REC
|d OCLCO
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d M8D
|d OCLCO
|d UX1
|d OCLCQ
|d OCLCA
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
016 |
7 |
|
|a 101308934
|2 DNLM
|
016 |
7 |
|
|a 013828924
|2 Uk
|
019 |
|
|
|a 181368925
|a 243547467
|a 536135671
|a 609848709
|a 646816155
|a 647768544
|a 722718396
|a 728056903
|a 746577186
|a 816339975
|a 961567175
|a 962628470
|a 1055392188
|a 1062925111
|a 1081279773
|
020 |
|
|
|a 0470518146
|q (electronic bk.)
|
020 |
|
|
|a 9780470518144
|q (electronic bk.)
|
020 |
|
|
|a 9780470518137
|
020 |
|
|
|a 0470518138
|
020 |
|
|
|a 1282348256
|
020 |
|
|
|a 9781282348257
|
020 |
|
|
|a 0470319380
|q (alk. paper)
|
020 |
|
|
|a 9780470319383
|q (alk. paper)
|
020 |
|
|
|z 9780470319383
|q (alk. paper)
|
020 |
|
|
|z 9780470518144
|
024 |
7 |
|
|a 10.1002/9780470518137
|2 doi
|
029 |
1 |
|
|a AU@
|b 000051380292
|
029 |
1 |
|
|a CHNEW
|b 000935473
|
029 |
1 |
|
|a CHVBK
|b 480158177
|
029 |
1 |
|
|a DEBBG
|b BV043391282
|
029 |
1 |
|
|a DEBBG
|b BV044139990
|
029 |
1 |
|
|a DEBSZ
|b 421852445
|
029 |
1 |
|
|a DEBSZ
|b 484983970
|
029 |
1 |
|
|a NZ1
|b 13340382
|
029 |
1 |
|
|a AU@
|b 000066760990
|
029 |
1 |
|
|a AU@
|b 000072993767
|
035 |
|
|
|a (OCoLC)609997294
|z (OCoLC)181368925
|z (OCoLC)243547467
|z (OCoLC)536135671
|z (OCoLC)609848709
|z (OCoLC)646816155
|z (OCoLC)647768544
|z (OCoLC)722718396
|z (OCoLC)728056903
|z (OCoLC)746577186
|z (OCoLC)816339975
|z (OCoLC)961567175
|z (OCoLC)962628470
|z (OCoLC)1055392188
|z (OCoLC)1062925111
|z (OCoLC)1081279773
|
037 |
|
|
|a 10.1002/9780470518137
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
050 |
|
4 |
|a RC694.3
|b .A77 2007eb
|
060 |
|
4 |
|a 2007 M-265
|
060 |
|
4 |
|a WG 300
|b A834m 2007
|
072 |
|
7 |
|a MED
|x 010000
|2 bisacsh
|
072 |
|
7 |
|a MJ
|2 bicssc
|
082 |
0 |
4 |
|a 616.1/42
|2 22
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Askari, Arman T.
|
245 |
1 |
0 |
|a Management strategies in antithrombotic therapy /
|c by Arman Askari and Adrian W. Messerli.
|
260 |
|
|
|a Chichester ;
|a Hoboken, N.J. :
|b John Wiley and Sons,
|c ©2007.
|
300 |
|
|
|a 1 online resource (350 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Thrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction. More and more individuals are stricken with an acute MI and undergo a percutaneous coronary intervention (PCI). Several reasons apply, including an increasingly aged population, the growing burden of chronic risk factors such as diabetes, obesity, sedentary behaviour, and improvements in ear.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Thrombolytic therapy.
|
650 |
|
0 |
|a Thrombosis
|x Treatment.
|
650 |
|
0 |
|a Fibrinolytic agents.
|
650 |
1 |
2 |
|a Coronary Thrombosis
|x drug therapy
|
650 |
1 |
2 |
|a Heart Diseases
|x drug therapy
|
650 |
2 |
2 |
|a Fibrinolytic Agents
|x therapeutic use
|
650 |
|
2 |
|a Thrombolytic Therapy
|
650 |
|
2 |
|a Fibrinolytic Agents
|
650 |
|
6 |
|a Thrombolyse.
|
650 |
|
6 |
|a Thrombose
|x Traitement.
|
650 |
|
6 |
|a Fibrinolytiques.
|
650 |
|
7 |
|a MEDICAL
|x Cardiology.
|2 bisacsh
|
650 |
|
7 |
|a Fibrinolytic agents
|2 fast
|
650 |
|
7 |
|a Thrombolytic therapy
|2 fast
|
700 |
1 |
|
|a Messerli, Adrian W.
|
758 |
|
|
|i has work:
|a Management strategies in antithrombotic therapy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFPMWT77kgyF4t4cwkmprm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Askari, Arman T.
|t Management strategies in antithrombotic therapy.
|d Chichester ; Hoboken, N.J. : John Wiley and Sons, ©2007
|w (DLC) 2007024176
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=470145
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 3486
|
938 |
|
|
|a Baker and Taylor
|b BTCP
|n BK0007901287
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL470145
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10297756
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 323149
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 234825
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3036189
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2940733
|
994 |
|
|
|a 92
|b IZTAP
|